WealthTrust Fairport’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

WealthTrust Fairport’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.07M	Buy	7,097 +5,901	+493%	+$849K	0.1%	105
2018 Q4	$149K	Sell	1,196 -6,681	-85%	-$914K	0.02%	168
2018 Q3	$1.25M	Buy	+7,877	New	+$1.19M	0.12%	95
2016 Q1	–	Sell	-5,360	Closed	-$606K	–	143
2015 Q4	$606K	Buy	5,360 +3,155	+143%	+$340K	0.08%	105
2015 Q3	$223K	Buy	+2,205	New	+$262K	0.03%	122

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

WealthTrust Fairport's FBT Position: Q1 2019 in Review

WealthTrust Fairport increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 493% in Q1 2019, buying an estimated $849K and bringing the position to 7,097 shares worth $1.07M. The position accounts for 0.1% of the portfolio, ranked #105.

WealthTrust Fairport first reported a position in FBT in Q3 2015 and has held it in 5 quarters since. The position peaked at $1.25M in Q3 2018. 227 funds tracked by Wall St. Rank hold FBT as of Q1 2019.

WealthTrust Fairport held 7,097 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.07M as of Q1 2019.
WealthTrust Fairport bought 5,901 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2019, an estimated $849K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.1% of WealthTrust Fairport's portfolio in Q1 2019, its #105 holding.
WealthTrust Fairport first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2015 and has held it in 5 quarters since.
WealthTrust Fairport's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.25M in Q3 2018.
227 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2019.

Based on WealthTrust Fairport's 13F filing for Q1 2019, filed 15 May 2019.